CD274 and melanoma: A study by Zaretsky J.M. et al. [73] showed that in some individuals who exhibited an initial positive response to anti-PD-1 therapy, melanoma cells demonstrated the presence of PD-L1 before treatment, but upon experiencing a relapse, PD-L1 expression was lost.